Although our previous study demonstrated that loss of HNRNPA2B1 inhibited the growth and metastasis of ovarian cancer, this oncogenic role of HNRNPA2B1 is likely independent of m6A RNA methylation (Yang et al., 2020). Here, HNRNPA2B1 is linked to ovarian carcinoma.